These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36253798)

  • 1. Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment.
    Squassina A; Meloni A; Congiu D; Bosganas P; Patrinos GP; Lin R; Turecki G; Severino G; Ardau R; Chillotti C; Pisanu C
    Hum Genomics; 2022 Oct; 16(1):45. PubMed ID: 36253798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.
    Squassina A; Pisanu C; Congiu D; Caria P; Frau D; Niola P; Melis C; Baggiani G; Lopez JP; Cruceanu C; Turecki G; Severino G; Bocchetta A; Vanni R; Chillotti C; Del Zompo M
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1241-7. PubMed ID: 27084304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of telomerase reverse transcriptase positively correlates with duration of lithium treatment in bipolar disorder.
    Lundberg M; Biernacka JM; Lavebratt C; Druliner B; Ryu E; Geske J; Colby C; Boardman L; Frye M; Schalling M
    Psychiatry Res; 2020 Apr; 286():112865. PubMed ID: 32114208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-aging effects of lithium in lymphoblastoid cell lines from patients with bipolar disorder and controls.
    Fries GR; Zamzow MJ; Colpo GD; Monroy-Jaramillo N; Quevedo J; Arnold JG; Bowden CL; Walss-Bass C
    J Psychiatr Res; 2020 Sep; 128():38-42. PubMed ID: 32516629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment.
    Pisanu C; Congiu D; Manchia M; Caria P; Cocco C; Dettori T; Frau DV; Manca E; Meloni A; Nieddu M; Noli B; Pinna F; Robledo R; Sogos V; Ferri GL; Carpiniello B; Vanni R; Bocchetta A; Severino G; Ardau R; Chillotti C; Zompo MD; Squassina A
    Pharmacogenomics; 2020 Jun; 21(8):533-540. PubMed ID: 32372689
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres.
    Martinsson L; Wei Y; Xu D; Melas PA; Mathé AA; Schalling M; Lavebratt C; Backlund L
    Transl Psychiatry; 2013 May; 3(5):e261. PubMed ID: 23695236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients.
    Mizrahi L; Choudhary A; Ofer P; Goldberg G; Milanesi E; Kelsoe JR; Gurwitz D; Alda M; Gage FH; Stern S
    Mol Psychiatry; 2023 Oct; 28(10):4280-4293. PubMed ID: 37488168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased leucocyte telomere length in male patients with chronic bipolar disorder: lack of effect of long-term lithium treatment.
    Ferensztajn-Rochowiak E; Kurczewska E; Rubiś B; Lulkiewicz M; Hołysz H; Rybakowski F; Rybakowski JK
    Acta Neuropsychiatr; 2021 Dec; 33(6):299-306. PubMed ID: 34369336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.
    Squassina A; Costa M; Congiu D; Manchia M; Angius A; Deiana V; Ardau R; Chillotti C; Severino G; Calza S; Del Zompo M
    Pharmacol Res; 2013 Jul; 73():1-7. PubMed ID: 23619527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder.
    Cattane N; Courtin C; Mombelli E; Maj C; Mora C; Etain B; Bellivier F; Marie-Claire C; Cattaneo A
    BMC Psychiatry; 2022 Oct; 22(1):665. PubMed ID: 36303132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium response in bipolar disorder correlates with improved cell viability of patient derived cell lines.
    Paul P; Iyer S; Nadella RK; Nayak R; Chellappa AS; Ambardar S; Sud R; Sukumaran SK; Purushottam M; Jain S; ; Viswanath B
    Sci Rep; 2020 May; 10(1):7428. PubMed ID: 32366893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine.
    Mishra HK; Mandyam AD; Trenet W; Wei H; Nievergelt CM; Maihofer AX; Shilling PD; Alda M; Gershon E; McInnis MG; ; Kelsoe JR; McCarthy MJ
    Neuropharmacology; 2023 Mar; 226():109410. PubMed ID: 36608815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder.
    Rizzo LB; Do Prado CH; Grassi-Oliveira R; Wieck A; Correa BL; Teixeira AL; Bauer ME
    Bipolar Disord; 2013 Dec; 15(8):832-8. PubMed ID: 24021055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
    Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
    Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abelson Helper Integration Site 1 haplotypes and peripheral blood expression associates with lithium response and immunomodulation in bipolar patients.
    Sakrajda K; Bilska K; Czerski PM; Narożna B; Dmitrzak-Węglarz M; Heilmann-Heimbach S; Brockschmidt FF; Herms S; Nöthen MM; Cichon S; Więckowska B; Rybakowski JK; Pawlak J; Szczepankiewicz A
    Psychopharmacology (Berl); 2024 Apr; 241(4):727-738. PubMed ID: 38036661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy.
    Milanesi E; Voinsky I; Hadar A; Srouji A; Maj C; Shekhtman T; Gershovits M; Gilad S; Chillotti C; Squassina A; Potash JB; Schulze TG; Goes FS; Zandi P; Kelsoe JR; Gurwitz D
    World J Biol Psychiatry; 2019 Jul; 20(6):449-461. PubMed ID: 28854847
    [No Abstract]   [Full Text] [Related]  

  • 17. Is bipolar disorder associated with accelerating aging? A meta-analysis of telomere length studies.
    Colpo GD; Leffa DD; Köhler CA; Kapczinski F; Quevedo J; Carvalho AF
    J Affect Disord; 2015 Nov; 186():241-8. PubMed ID: 26253905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium-induced Clock Gene Expression in Lymphoblastoid Cells of Bipolar Affective Patients.
    Kittel-Schneider S; Schreck S; Ziegler C; Weißflog L; Hilscher M; Schwarz R; Schnetzler L; Neuner M; Reif A
    Pharmacopsychiatry; 2015 Jul; 48(4-5):145-9. PubMed ID: 26011568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders.
    Moreira J; Courtin C; Geoffroy PA; Curis E; Bellivier F; Marie-Claire C
    Psychiatry Res; 2017 May; 251():217-220. PubMed ID: 28214779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients.
    Papadima EM; Niola P; Melis C; Pisanu C; Congiu D; Cruceanu C; Lopez JP; Turecki G; Ardau R; Severino G; Chillotti C; Del Zompo M; Squassina A
    J Mol Neurosci; 2017 Aug; 62(3-4):304-308. PubMed ID: 28616776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.